Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 25;26(11):3163.
doi: 10.3390/molecules26113163.

Synthesis of Novel Halogenated Heterocycles Based on o-Phenylenediamine and Their Interactions with the Catalytic Subunit of Protein Kinase CK2

Affiliations

Synthesis of Novel Halogenated Heterocycles Based on o-Phenylenediamine and Their Interactions with the Catalytic Subunit of Protein Kinase CK2

Maria Winiewska-Szajewska et al. Molecules. .

Abstract

Protein kinase CK2 is a highly pleiotropic protein kinase capable of phosphorylating hundreds of protein substrates. It is involved in numerous cellular functions, including cell viability, apoptosis, cell proliferation and survival, angiogenesis, or ER-stress response. As CK2 activity is found perturbed in many pathological states, including cancers, it becomes an attractive target for the pharma. A large number of low-mass ATP-competitive inhibitors have already been developed, the majority of them halogenated. We tested the binding of six series of halogenated heterocyclic ligands derived from the commercially available 4,5-dihalo-benzene-1,2-diamines. These ligand series were selected to enable the separation of the scaffold effect from the hydrophobic interactions attributed directly to the presence of halogen atoms. In silico molecular docking was initially applied to test the capability of each ligand for binding at the ATP-binding site of CK2. HPLC-derived ligand hydrophobicity data are compared with the binding affinity assessed by low-volume differential scanning fluorimetry (nanoDSF). We identified three promising ligand scaffolds, two of which have not yet been described as CK2 inhibitors but may lead to potent CK2 kinase inhibitors. The inhibitory activity against CK2α and toxicity against four reference cell lines have been determined for eight compounds identified as the most promising in nanoDSF assay.

Keywords: cell toxicity; differential scanning fluorimetry; halogenated heterocycles; hydrophobic contribution; inhibitory activity; kinase CK2; ligand binding; molecular modeling.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Structures of potent inhibitors of kinase CK2. Bolded fragments represent the common o-phenylenediamine substructure.
Scheme 1
Scheme 1
Synthesis of compounds 27. Conditions: (a) SOCl2, Et3N, DCM, 40 °C; (b) TFA, HCl reflux; (c) HOCH2COOH, HCl, H2O, reflux; (d) CDI, DMF, RT; (e) 40% glyoxal solution, EtOH, reflux; (f) oxalic acid, DMF, 120 °C.
Figure 2
Figure 2
Effect of substitution at the two distant positions of the benzene ring with a halogen atom on HPLC-derived hydrophobicity index (log(τ)) (A). The same values are represented relative to the unsubstituted compound of the same scaffold (B).
Figure 3
Figure 3
Correlation between HPLC-derived hydrophobicity index (log(τ)) and the ΔTm determined using nanoDSF.
Figure 4
Figure 4
Correlation between cell viability, IC50, and hydrophobicity of tested compounds, log(τ).
Figure 5
Figure 5
Correlation between the calculated Gibbs free energy of binding of synthesized compounds to CK2 obtained from molecular modeling (ΔGbind) and the ΔTm, estimated with the aid of nanoDSF.

Similar articles

Cited by

References

    1. Meggio F., Pinna L.A. One-thousand-and-one substrates of protein kinase CK2? FASEB J. 2003;17:349–368. doi: 10.1096/fj.02-0473rev. - DOI - PubMed
    1. Gotz C., Montenarh M. Protein kinase CK2 in development and differentiation. Biomed. Rep. 2017;6:127–133. doi: 10.3892/br.2016.829. - DOI - PMC - PubMed
    1. Gietz R.D., Graham K.C., Litchfield D.W. Interactions between the subunits of casein kinase II. J. Biol. Chem. 1995;270:13017–13021. doi: 10.1074/jbc.270.22.13017. - DOI - PubMed
    1. Krippner-Heidenreich A., Talanian R.V., Sekul R., Kraft R., Thole H., Ottleben H., Luscher B. Targeting of the transcription factor Max during apoptosis: Phosphorylation-regulated cleavage by caspase-5 at an unusual glutamic acid residue in position P1. Biochem. J. 2001;358:705–715. doi: 10.1042/bj3580705. - DOI - PMC - PubMed
    1. Desagher S., Osen-Sand A., Montessuit S., Magnenat E., Vilbois F., Hochmann A., Journot L., Antonsson B., Martinou J.C. Phosphorylation of bid by casein kinases I and II regulates its cleavage by caspase 8. Mol. Cell. 2001;8:601–611. doi: 10.1016/S1097-2765(01)00335-5. - DOI - PubMed

MeSH terms